Given their opposing impact on breast cancer risk, some have proposed that the adiponectin: leptin ratio, rather than levels of individual adipokines, may be more informative for evaluating breast cancer risk profile [114,115]. This evidence concerns the gene ADIPOQ and breast cancer.